Evidence map›Paper›PMID 27298494›Full record

ArticleIndian journal of pharmacology

Verification of five pharmacogenomics-based warfarin administration models.

Meiqin Lin, Liangping Yu, Hanfan Qiu, Qimin Wang, Jing Zhang, Hongtao Song

Abstract readValidation Study
In one paragraph

Article in Indian journal of pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Warfarin dosing algorithms: A systematic review.British journal of clinical pharmacology · 2021
    Pooled it
  2. Trial
  3. Article
  4. Developing Chinese race-specific warfarin dose prediction algorithms.International journal of clinical pharmacy · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Meiqin LinDepartment of Pharmacy, Fuzhou General Hospital of Nanjing Command, PLA, Fuzhou 350025, China.
Liangping YuDepartment of Pharmacy, Zhongshan Hospital Affiliated to Xiamen University, Xiamen 361100, China.
Hanfan QiuDepartment of Cardiac Surgery, Union Hospital, Fujian Medical University, Fuzhou 350001, China.
Qimin WangDepartment of Cardiac Surgery, Union Hospital, Fujian Medical University, Fuzhou 350001, China.
Jing ZhangDepartment of Pharmacy, Fuzhou General Hospital of Nanjing Command, PLA, Fuzhou 350025, China.
Hongtao SongDepartment of Pharmacy, Fuzhou General Hospital of Nanjing Command, PLA, Fuzhou 350025, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aims to screen and validate five individual warfarin dosing models (four Asian model algorithms, namely, Ohno, Wen, Miao, Huang, and the algorithm of International Warfarin Pharmacogenetic Consortium, namely IWPC algorithm) with the aim of evaluating their accuracy, practicality, and safety. MATERIALS AND

methodsPatients' CYP2C9*3 and VKORC1-1639G >A genes were genotyped, and patient-related information and steady warfarin doses were recorded. The difference between the predicted dose and actual maintenance dose of each model was compared.

resultsThe prediction accuracies of the Huang and Wen models were the highest. In terms of clinical practicality, the Huang model rated the highest for the low-dose group, whereas the Ohno and IWPC models rated the highest for the middle-dose group. The models tended to markedly overpredict the doses in the low-dose group, especially the IWPC model. The Miao model tended to severely underpredict the doses in the middle-dose group, whereas no model exhibited severe overprediction.

conclusionsSince none of the models ranked high for all the three criteria considered, the impact of various factors should be thoroughly considered before selecting the most appropriate model for the region's population.

Indexed as

Models, TheoreticalPharmacogeneticsAnticoagulantsCytochrome P-450 CYP2C9HumansWarfarinAnticoagulantsCytochrome P-450 CYP2C9WarfarinMechanical heart valve replacementmodelpharmacogenomicsverificationwarfarin

Identifiers

PMID27298494
PMCPMC4899997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.